Impact of KRAS G12C mutation on the efficacy of chemoradiotherapy in patients with unresectable stage II or III non-small cell lung cancer
KRAS G12C突变对不可切除的II期或III期非小细胞肺癌患者化疗放疗疗效的影响
期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2025.1675825
Cabon, Jean; Lerouge, Delphine; Thureau, Sebastien; Balosso, Jacques; Guigo, Marin; Gervais, Radj; Dubos, Catherine; Dô, Pascal; Demontrond, Pierre; Curcio, Hubert; Deshayes, Simon; Madelaine, Jeannick; Leite Ferreira, Dimitri; Jacson, Leonard; Lecrosnier, Kilian; Chevalier, François; Guisier, Florian; Dantoing, Edouard; Leconte, Alexandra; Christy, François; Césaire, Mathieu